Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug;10(8):E661-E663.
doi: 10.21037/jtd.2018.07.130.

ESTS staging guidelines for non-small cell lung cancer: a good guide to best ever accuracy and high survival rate

Akif Turna  1
Affiliations
Comment

ESTS staging guidelines for non-small cell lung cancer: a good guide to best ever accuracy and high survival rate

Akif Turna. J Thorac Dis. 2018 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Survival of all patients who had resectional surgery.
See this image and copyright information in PMC

Comment on

References

    1. Vallières E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-59. 10.1097/JTO.0b013e3181b27799 - DOI - PubMed
    1. Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e278S-313S. - PubMed
    1. Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2015;10:1675-84. - PubMed
    1. Pang Z, Yang Y, Ding N, et al. Optimal managements of stage III(N2) non-small cell lung cancer patients: a population-based survival analysis. J Thorac Dis 2017;9:4046-56. 10.21037/jtd.2017.10.47 - DOI - PMC - PubMed
    1. Chen Y, Peng X, Zhou Y, et al. Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis. World J Surg Oncol 2018;16:8. 10.1186/s12957-018-1313-x - DOI - PMC - PubMed

LinkOut - more resources